Immunomedics Inc (NASDAQ:IMMU)

20.67
Delayed Data
As of Dec 13
 -0.06 / -0.29%
Today’s Change
11.55
Today|||52-Week Range
21.50
+44.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues5.7M3.2M3.1M0.00
 
 
 
 
Cost of Goods Sold264.9K421.5K482.7K0.00
 
 
 
 
Depreciation And Amortization578.1K737.7K900.0K2.1M
 
 
 
 
 
 
Operating ExpensesGross Income4.8M2.1M1.7M-2.1M
 
 
 
 
 
General Expenses51.0M61.1M80.9M142.4M
 
 
 
 
 
Research And Development41.2M53.5M51.8M93.9M
 
 
 
 
 
Total Operating Expenses51.9M62.2M82.2M144.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.2M-59.0M-79.1M-144.5M
 
 
 
 
 
Extraordinary Credit0.000.000.001.6M
 
 
Extraordinary Charge0.000.00-68.7M-897.0K
 
 
 
Interest Expense On Debt2.1M5.5M5.5M20.0M
 
 
 
 
 
Other Expenses9.8K-37.5K-307.3K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.1M-64.2M-153.2M-157.7M
 
 
 
 
 
Income Taxes-58.2K-5.1M-20.9K0.00
 
 
 
 
Minority Interest-121.6K-98.8K-60.3K-81.0K
 
 
 
 
 
Net Income-48.0M-59.0M-153.2M-157.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS93.3M94.8M104.5M188.6M
 
 
 
 
 
Shares To Calculate EPS Diluted93.3M94.8M104.5M188.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.62-$1.47-$0.84
 
 
 
 
 
EPS Diluted-$0.51-$0.62-$1.47-$1.67